about
Role of microglia in central nervous system infectionsNeuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's diseaseAnti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose ControlGlia and alpha-synuclein in neurodegeneration: A complex interactionUncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repairCXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systemsCB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease.Neuroanatomical changes in Parkinson's disease in relation to cognition: An updateEffect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosisFlavonoids: modulators of brain function?Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityAge-related changes in glial cells of dopamine midbrain subregions in rhesus monkeysSpinal cord pathology in alpha-synuclein transgenic miceSystemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculatureExpression of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) and its roles in activated microglia in vivo and in vitroMALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain.CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's diseaseJNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease.Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Involvement of Heme Oxygenase-1 Induction in the Cytoprotective and Immunomodulatory Activities of Viola patrinii in Murine Hippocampal and Microglia Cells.The potential role of vascular endothelial growth factor in the central nervous system.Comorbidities in Neurology: Is adenosine the common link?Microglia in Alzheimer brain: a neuropathological perspective.Neurodegeneration and neuroprotection in Parkinson disease.New insights on endocannabinoid transmission in psychomotor disorders.A simplified method for isolating highly purified neurons, oligodendrocytes, astrocytes, and microglia from the same human fetal brain tissue.Manganese chloride stimulates rat microglia to release hydrogen peroxideVasoactive intestinal peptide family as a therapeutic target for Parkinson's disease.The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation through the Regulation of Microglial Inflammatory ActivationReactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's diseaseCentral and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease.TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF.Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's DiseaseInhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTPThe interactions of flavonoids within neuronal signalling pathways.Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
P2860
Q24563024-F087D3B5-4854-434E-BB7A-8333FCA4C566Q24630237-489D9B6E-7A30-4BE9-AD21-C6543E036B45Q26750746-18878DBF-49BA-4524-AB13-5422F621702BQ26851153-3C06B5A5-2DF3-4121-9A67-D2615EE2C40CQ26865502-57B61071-8D82-42FC-806E-E8D6D9406568Q26992010-596866F1-87B3-4883-8F00-996A0CD23302Q27324500-B477DF48-6655-4F96-8A24-DD37D1246B40Q28067803-E94F82FC-0427-41D9-9DFC-638E1664C844Q28211897-66588C4E-6D02-42E0-84D1-0730390F409AQ28281453-50278A6C-AA97-442C-BD85-6FAC85E5C857Q30991616-8FF793FB-DCA9-4F49-ABB9-AF8BE71A6DAFQ33540157-518D81BD-2D2A-4144-8ED9-88C7AF6E2D1CQ33751118-B3E6F588-BAD5-464C-A8C0-CC10D35A0841Q33859902-08A218C4-FAF6-4820-B7E3-9CA5821D2498Q34211292-62260E81-4688-4E97-8346-F3607D092D0BQ34237258-6C2B21DB-43FE-4F00-A83C-F2EE961EF5FFQ34571642-E5502BB0-6E9D-479D-88FD-42573F55ED75Q35069025-BE7B2D55-2480-4DB8-8A51-6446EA7E8F0FQ35580088-B800BDD5-1379-4AAC-BCA0-5580CCA16EA9Q35736273-76E6E524-FF6F-4DF9-A9B3-F1447CB5A9DAQ35806742-4986D5F8-CD77-4741-9018-651298EAFC95Q35872370-CE033024-3F89-4FCA-9476-60A6E4D996A2Q35939261-274BE9F1-AE22-4E76-B1E4-CCBD6D295A8EQ35956389-37EE2863-2698-4D91-9420-5AED5A079DD9Q35986371-FBA7627F-5604-41AD-9F78-90FA3EED56A0Q36045259-3C8D6497-5757-41E9-9B64-7F23BB6379D2Q36074595-1FFF30B8-67D2-426F-9EE9-B129067664D0Q36158410-FA76F247-40A0-443A-ACAB-8BE8DB7F15EAQ36178038-A9EB00E4-7A09-4F40-BB88-2D92B63A81C6Q36268291-EAC4F0AC-8A8A-452A-ACE1-8C17E195AB05Q36323477-199A740D-CD0E-430D-944E-901B1970BCDAQ36573418-9D1968EE-4FF0-4A8F-A34B-01335A3F930DQ36576487-5E35B36E-E380-452F-8B7F-8F5B0BDB6654Q36741828-D83BC2E0-18E4-44FA-B0A7-431BB928C399Q36824652-57359117-05D9-4A4C-B350-7842568EEDF7Q37211800-B848BCAD-508B-47F4-99E4-79872A2371EFQ37250909-FAAF4313-BB61-494C-BD0B-484D02458296Q37292416-9F2298B2-8C18-4E79-86AC-1E2CE7E97616Q37333346-186CA973-3AC5-4062-8336-DFC3B01B2370Q37371387-0E4E686A-49E9-4780-9EED-40D4C0290E90
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of glial cells in Parkinson's disease.
@ast
The role of glial cells in Parkinson's disease.
@en
The role of glial cells in Parkinson's disease.
@nl
type
label
The role of glial cells in Parkinson's disease.
@ast
The role of glial cells in Parkinson's disease.
@en
The role of glial cells in Parkinson's disease.
@nl
prefLabel
The role of glial cells in Parkinson's disease.
@ast
The role of glial cells in Parkinson's disease.
@en
The role of glial cells in Parkinson's disease.
@nl
P2093
P1476
The role of glial cells in Parkinson's disease.
@en
P2093
P304
P356
10.1097/00019052-200108000-00009
P577
2001-08-01T00:00:00Z